• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Basic Research for AIDS control

Research Project

Project/Area Number 10180103
Research Category

特定領域研究

Allocation TypeSingle-year Grants
Review Section Biological Sciences
Research InstitutionKyoto University

Principal Investigator

UCHIYAMA Takashi  Kyoto University, Graduate School of Medicine, professor, 医学研究科, 教授 (80151900)

Co-Investigator(Kenkyū-buntansha) MITUYA Yoshiaki  Kumamoto University, Faculty of Medicine, Professor, 医学部, 教授 (20136724)
MATSUSHITA Shuzo  Kumamoto University, Center for AIDS Research, Professor, エイズ学研究センター, 教授 (00199788)
KOYANAGI Yoshio  Tohoku University, Graduate School of Medicine, Professor, 医学系研究科, 教授 (80215417)
HORI Toshiyuki  Kyoto University, Graduate School of Medicine, Lecturer, 医学研究科, 講師 (70243102)
Project Period (FY) 2002
KeywordsHIV-1 / Host Factors / Pathophysiology / Immune response / AIDS Control / Chemokine / Chemokine Receptor
Research Abstract

This research project focused on AIDS control, had been done for 4 years from 1998 to 2001, and divided into three major groups which had their own goals. These are as follows ; A01 : Host factors necessary for HIV-1 replication, in which we intended to better understand the viral life cycle by identifying host factors necessary for HIV-1 replication and elucidating their interaction with the virus. A02 : Pathophysiology and immunology of HIV-1 infection, in which we tried to elucidate the mechanism of immune response to HIV-1, establishment of persistent infection, and destruction of immune system in infected individuals. A03 : Prevention and control of AIDS, in which we pursued to establish a novel therapeutic strategy targeted to each step of the viral life cycle as well as to elucidate the mechanism of drug resistance of HIV-1. We had been worked from these three major aspects and got 4 major research results as follows. 1) Studies on chemokine and chemokine receptors. 2) Host factors which bind to tat protein to regulate the viral transcription. 3) Specific immune response to HIV-1 mainly focusing on HIV-1-specific CTL response and basic research for vaccine development. 4) Analysis of pathophysiology of HIV-1 infection and pathogenic factors using unique animal models. Among them, 1) studies on chemokine and chemokine receptors were the most important issue of this project and done by many investigators across the subgroups intensively, resulting in the major progress in this field including the elucidation of the detailed mechanism of viral entry through chemokine receptors, development of a novel treatment targeted for chemokine receptors, genetic analysis of polymorphism of chemokine/chemokine receptors affecting progression of AIDS. These results were outstanding worldwide.

  • Research Products

    (15 results)

All Other

All Publications (15 results)

  • [Publications] Yonezawa A.: "Natural Alpha Interferon-Producing Cells Respond to Human Immunodeficiency Virus Type I with Alpha Interferon Production and Maturation into Dendritic Cells"J.Virol.. 77(6). 3777-3784 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yonezawa A.: "Replacement of the V3 Region of gp12O with SDF-1 Preserves the Infectivity of T-Cell Line-Tropic Human Immunodeficiency Virus Type 1"J.Virol.. 75(9). 4258-4267 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Ichiyama K.: "A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity"Proc.Natl.Acad.Sci. USA. 100(7). 4185-4190 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Miura Y.: "Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection"Proc.Natl.Acad.Sci. USA. 100(5). 2777-2782 (2003)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Kimura T.: "Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeticiency virus during highly active antiretroviral therapy"J.Infect.Dis.. 185(1). 53-60 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Gatanada H.: "Amino acid substitutions in non-cleavage sites of the gag region are indispensable for high level HIV-1 resistance to protease inhibitors"J.Biol.Chem.. 277. 5952-5961 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Mituya H.: "Textbook of AIDS Medicine"Williams & Wilkins. 1064 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Yonezawa A. et al: "Natural Alpha Interferon-Producing Cells Respond to Human Immunodeficiency Virus Type 1 with Alpha Interferon Production and Maturation into Dendritic Cells"J.Virol.. 77(6). 3777-3784 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Yonezawa A. et al: "Replacement of the V3 Region of gp 120 with SDF-1 Preserves the Infectivity of T-Cell Line-Tropic Human Immunodeficiency Virus Type 1"J. Virol. 75(9). 4258-4267 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Ichiyama K. et al: "A duodenally absorbable CXC chemokine receptor 4 antagonist, KRH-1636, exhibits a potent and selective anti-HIV-1 activity."Proc. Natl. Acad. Sci. USA. 100(7). 4185-4190 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miura Y. et al: "Tumor necrosis factor-related apoptosis-inducing ligand induces neuronal death in a murine model of HIV central nervous system infection."Proc. Natl. Acad. Sci. USA. 100(5). 2777-2782 (2003)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Kimura T. et al: "Reconstitution of spontaneous neutralizing antibody response against autologous human immunodeficiency virus during highly active antiretroviral therapy"J. Infect. Dis.. 185(1). 53-60 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Wang FX, et al: "Emergence of autologous neutralization-resistant variants from preexisting human immunodeficiency virus (HIV) quasi species during virus rebound in HIV type 1-infected patients undergoing highly active antiretroviral therapy"J. Infect. Dis.. 185(5). 608-617 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Gatanada H. et al: "Amino acid substitutions in non-cleavage sites of the gag region are indispensable for high level HIV-1 resistance to protease inhibitors"J. Biol. Chem.. 277. 5952-5961 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Miyakawa T. et al: "Identification of amino acid residues critical for LD78β (a variant of human macrophage inflammatory protein-1 α) binding to CCR5 and inhibition of R5 HIV-1 replication"J. Biol. Chem.. 277. 4649-4655 (2002)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2004-04-14  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi